Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 27th January 2017
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EMA approves 11 new veterinary medicines
pharmacy
EMA recommended 11 new veterinary medicines for marketing authorisations in 2016.
EU agency publishes 2016 highlights
 
The European Medicines Agency (EMA) has published highlights from its recommendations for veterinary medicines in 2016, which includes marketing authorisations for 11 new products.

The following medicines were recommended for marketing authorisations:
  • VarroMed: an anti-parasitic medicine to treat Varroa mite infestation in honey bee colonies, which is thought to be the most significant parasitic health concern facing honey bees globally.
  • Evalon: a vaccine that protects chickens against coccidiosis, a parasitic disease of the intestinal tract.
  • CLYNAV: a biotechnological vaccine that protects Atlantic salmon from pancreas disease, caused by infection with salmonid alphavirus subtype 3.
  • Coliprotec F4/F18: a vaccine to protect against porcine post-weaning diarrhoea caused by E. coli in pigs.
  • Eravac: a vaccine to protect rabbits against a new variant of rabbit haemorrhagic disease virus (RHDV2).
  • Letifend: a biotechnological vaccine for dogs to protect them from leishmaniasis.

Other new medicines include HALAGON for newborn calves, Cepedex, Sedadex and Sevohale for dogs, and Cepedex, Sedadex and Stronghold plus for cats.

Six medicines contain a new active substance: Coliprotec F4/F18, CLYNAV, Eravac, VarroMed, Letifend and Stronghold plus.

The use of four known substances was also expanded in 2016. DRAXXIN can be used against swine respiratory disease, Profender can be used as a spot-on solution for cats, Poulvac E. Coli can also be used in turkeys and Trifexis can be used to treat and prevent flea infestations in dogs.

EMA made a number of CVMP recommendations in 2016: to increase the withdrawal period for medicines containing gentamicin in cattle and pigs to enhance consumer safety; and to avoid administering gentamicin subcutaneously.

Environment protection measures should be taken to ensure altrenogest - a steroidal hormone used to treat young female pigs and mares - has no adverse effects on reproduction for aquatic organisms.

Medicines containing zinc oxide, used in medicated feeding stuff for piglets, were withdrawn and marketing authorisations refused, as these are considered harmful to the environment. Velactis was also suspended after serious adverse effects were reported in cattle.

Marketing authorisations were withdrawn for veterinary medicines containing colistin in combination with other antibiotics that are administered orally throughout the EU. EMA advises that colistin only be used as a second-line treatment in animals and sales should be minimised across the EU.

Become a member or log in to add this story to your CPD history

Birmingham Dogs Home makes urgent appeal

News Story 1
 Birmingham Dogs Home has issued an urgent winter appeal as it faces more challenges over the Christmas period.

The rescue centre has seen a dramatic increase in dogs coming into its care, and is currently caring for over 200 dogs. With rising costs and dropping temperatures, the charity is calling for urgent support.

It costs the charity £6,000 per day to continue its work.

Fi Harrison, head of fundraising and communications, said: "It's heart-breaking for our team to see the conditions some dogs arrive in. We really are their last chance and hope of survival."

More information about the appeal can be found here. 

Click here for more...
News Shorts
Avian flu confirmed at premises in Cornwall

A case of highly pathogenic avian influenza H5N1 has been detected in commercial poultry at a premises near Rosudgeon, Cornwall.

All poultry on the infected site will be humanely culled, and a 3km protection zone and 10km surveillance zone have been put in place. Poultry and other captive birds in the 3km protection zone must be housed.

The case is the second avian flu case confirmed in commercial poultry this month. The H5N5 strain was detected in a premises near Hornsea, East Riding of Yorkshire, in early November. Before then, the disease had not been confirmed in captive birds in England since February.

The UK chief veterinary officer has urged bird keepers to remain alert and practise robust biosecurity.

A map of the disease control zones can be found here.